The University of Texas at Austin

Science & Technology - Neurobiology RSS

  • Old Drug Holds New Promise

    Old Drug Holds New Promise

    By University Communications
    Published: July 8, 2012

    Exciting new findings in UT’s neurobiology labs suggest that rapamycin, an FDA-approved immunosuppressant used to control organ rejection in transplant patients, may be an effective therapy for Alzheimer’s, epilepsy, and even autism. Now a UT team led by Professor Kim Raab-Graham of the College of Natural Sciences’ Center for Learning and Memory is searching for …

    Watch this video

    Post a comment Comments (3)
    • Quote 2
      Mandy Skogebo said on July 13, 2012 at 3:38 p.m.
      Oh how I wish this were already available. I recently visited with my 80 year old grandmother and she has gone from being able to carry on a conversation to not remembering who I am in under 6 month. It's so hard to watch. :( Heartbreaking.
    • Quote 2
      SF said on July 12, 2012 at 1:34 p.m.
      Amazing breakthrough! Hope it comes completely to fruition! Longhorn Pride!

  • Neurobiology Features

    Singing the praise of science
    Singing the praise of science
    Third-year neurobiology major Da'Marcus Baymon studies statistics and its role in...
    Post a comment Comments (13)
    Army focuses on university research
    Army focuses on university research
    The United States Army has strong ties to The University of Texas at Austin in research...
    Post a comment Comments (1)
    Office hours: George Pollak's big idea
    Office hours: George Pollak's big idea
    For more than 35 years, neurobiologist George Pollak has been using echolocating...
    Comments Off No Comments